Roche P W, Triccas J A, Avery D T, Fifis T, Billman-Jacobe H, Britton W J
Centenary Institute of Cancer Medicine and Cell Biology, Newtown, Australia.
J Infect Dis. 1994 Nov;170(5):1326-30. doi: 10.1093/infdis/170.5.1326.
The immune responses of healthy recipients of Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine, tuberculosis (TB) patients, and contacts of TB patients were examined to three major secretory proteins of Mycobacterium tuberculosis, MPB59, MPB64, and MPB70. MPB59 evoked a T cell response in 78% of BCG vaccines, 62% of TB patients, and 60% of contacts. MPB64 and MPB70 were recognized by < 15% of BCG vaccinees, half of TB patients, and three-quarters of contacts. TB and leprosy patients had antibody responses to MPB59, but few had antibodies to MPB64 or MPB70. Hybridization of mycobacterial DNA with specific gene probes demonstrated the absence of a gene for MBP64 in the vaccine strain of BCG, but the MPB70 gene was found in all virulent and vaccine BCG strains tested. Since MPB64 and MPB70 can induce delayed-type hypersensitivity reactions in infected animals, either of these proteins may have potential as skin test reagents for detecting infection with M. tuberculosis.
对卡介苗(BCG)健康接种者、结核病(TB)患者以及TB患者的接触者针对结核分枝杆菌的三种主要分泌蛋白MPB59、MPB64和MPB70的免疫反应进行了检测。MPB59在78%的BCG接种者、62%的TB患者以及60%的接触者中引发了T细胞反应。MPB64和MPB70仅在不到15%的BCG接种者、一半的TB患者以及四分之三的接触者中被识别。TB和麻风病患者对MPB59有抗体反应,但对MPB64或MPB70有抗体的很少。用特异性基因探针进行的分枝杆菌DNA杂交显示,BCG疫苗株中不存在MBP64基因,但在所有测试的强毒株和BCG疫苗株中都发现了MPB70基因。由于MPB64和MPB70可在感染动物中诱导迟发型超敏反应,因此这两种蛋白中的任何一种都可能有潜力作为检测结核分枝杆菌感染的皮肤试验试剂。